These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 26215877)

  • 1. Evidence-based guideline summary: Evaluation, diagnosis, and management of facioscapulohumeral muscular dystrophy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine.
    Tawil R; Kissel JT; Heatwole C; Pandya S; Gronseth G; Benatar M; ;
    Neurology; 2015 Jul; 85(4):357-64. PubMed ID: 26215877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence-based guideline summary: evaluation, diagnosis, and management of congenital muscular dystrophy: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine.
    Kang PB; Morrison L; Iannaccone ST; Graham RJ; Bönnemann CG; Rutkowski A; Hornyak J; Wang CH; North K; Oskoui M; Getchius TS; Cox JA; Hagen EE; Gronseth G; Griggs RC;
    Neurology; 2015 Mar; 84(13):1369-78. PubMed ID: 25825463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations for the management of facioscapulohumeral muscular dystrophy in 2011.
    Attarian S; Salort-Campana E; Nguyen K; Behin A; Andoni Urtizberea J
    Rev Neurol (Paris); 2012 Dec; 168(12):910-8. PubMed ID: 22551571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early onset facioscapulohumeral dystrophy - a systematic review using individual patient data.
    Goselink RJM; Voermans NC; Okkersen K; Brouwer OF; Padberg GW; Nikolic A; Tupler R; Dorobek M; Mah JK; van Engelen BGM; Schreuder THA; Erasmus CE
    Neuromuscul Disord; 2017 Dec; 27(12):1077-1083. PubMed ID: 29102079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Facioscapulohumeral Muscular Dystrophy-Health Index: Development and evaluation of a disease-specific outcome measure.
    Varma A; Weinstein J; Seabury J; Rosero S; Engebrecht C; Wagner E; Zizzi C; Luebbe EA; Dilek N; McDermott MP; Kissel J; Sansone V; Heatwole C
    Muscle Nerve; 2023 Oct; 68(4):422-431. PubMed ID: 37610084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular diagnosis of facioscapulohumeral muscular dystrophy.
    Upadhyaya M; Cooper DN
    Expert Rev Mol Diagn; 2002 Mar; 2(2):160-71. PubMed ID: 11962336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic manifestations and symptom burden of facioscapulohumeral muscular dystrophy in a referral cohort.
    Kelly CR; Saw JL; Thapa P; Mandrekar J; Naddaf E
    Muscle Nerve; 2022 Apr; 65(4):415-421. PubMed ID: 35020192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An integrated approach in a case of facioscapulohumeral dystrophy.
    Pasotti S; Magnani B; Longa E; Giovanetti G; Rossi A; Berardinelli A; Tupler R; D'Antona G
    BMC Musculoskelet Disord; 2014 May; 15():155. PubMed ID: 24886582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The French National Registry of patients with Facioscapulohumeral muscular dystrophy.
    Guien C; Blandin G; Lahaut P; Sanson B; Nehal K; Rabarimeriarijaona S; Bernard R; Lévy N; Sacconi S; Béroud C
    Orphanet J Rare Dis; 2018 Dec; 13(1):218. PubMed ID: 30514324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined treatment with intravitreal bevacizumab and laser photocoagulation for exudative maculopathy in facioscapulohumeral muscular dystrophy.
    Matos R; Beato J; Silva M; Silva S; Brandão E; Falcão-Reis F; Penas S
    Ophthalmic Genet; 2017; 38(5):490-493. PubMed ID: 28121209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early-Onset Infantile Facioscapulohumeral Muscular Dystrophy: A Timely Review.
    Chen TH; Wu YZ; Tseng YH
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large genotype-phenotype study in carriers of D4Z4 borderline alleles provides guidance for facioscapulohumeral muscular dystrophy diagnosis.
    Ricci G; Mele F; Govi M; Ruggiero L; Sera F; Vercelli L; Bettio C; Santoro L; Mongini T; Villa L; Moggio M; Filosto M; Scarlato M; Previtali SC; Tripodi SM; Pegoraro E; Telese R; Di Muzio A; Rodolico C; Bucci E; Antonini G; D'Angelo MG; Berardinelli A; Maggi L; Piras R; Maioli MA; Siciliano G; Tomelleri G; Angelini C; Tupler R
    Sci Rep; 2020 Dec; 10(1):21648. PubMed ID: 33303865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Approaches in Facioscapulohumeral Muscular Dystrophy.
    Cohen J; DeSimone A; Lek M; Lek A
    Trends Mol Med; 2021 Feb; 27(2):123-137. PubMed ID: 33092966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facioscapulohumeral dystrophy in children: design of a prospective, observational study on natural history, predictors and clinical impact (iFocus FSHD).
    Goselink RJ; Schreuder TH; Mul K; Voermans NC; Pelsma M; de Groot IJ; van Alfen N; Franck B; Theelen T; Lemmers RJ; Mah JK; van der Maarel SM; van Engelen BG; Erasmus CE
    BMC Neurol; 2016 Aug; 16():138. PubMed ID: 27530735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early onset as a marker for disease severity in facioscapulohumeral muscular dystrophy.
    Goselink RJM; Mul K; van Kernebeek CR; Lemmers RJLF; van der Maarel SM; Schreuder THA; Erasmus CE; Padberg GW; Statland JM; Voermans NC; van Engelen BGM
    Neurology; 2019 Jan; 92(4):e378-e385. PubMed ID: 30568007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-based guideline summary: Evaluation, diagnosis, and management of congenital muscular dystrophy: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine.
    Haliloglu G; Topaloglu H
    Neurology; 2015 Oct; 85(16):1432. PubMed ID: 26481930
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical and genetic features of hearing loss in facioscapulohumeral muscular dystrophy.
    Lutz KL; Holte L; Kliethermes SA; Stephan C; Mathews KD
    Neurology; 2013 Oct; 81(16):1374-7. PubMed ID: 24042093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic counseling and testing for FSHD (facioscapulohumeral muscular dystrophy) in the Israeli population.
    Yanoov-Sharav M; Leshinsky-Silver E; Cohen S; Vinkler C; Michelson M; Lerman-Sagie T; Ginzberg M; Sadeh M; Lev D
    J Genet Couns; 2012 Aug; 21(4):557-63. PubMed ID: 22109111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facioscapulohumeral dystrophy.
    Kissel JT
    Semin Neurol; 1999; 19(1):35-43. PubMed ID: 10711987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facioscapulohumeral muscular dystrophy (FSHD): an enigma unravelled?
    Richards M; Coppée F; Thomas N; Belayew A; Upadhyaya M
    Hum Genet; 2012 Mar; 131(3):325-40. PubMed ID: 21984394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.